Are iPhone wait times signaling real demand, or just model mix differences?

UBS Evidence Lab reports mixed iPhone 17 wait times, complicating the assessment of true demand, as Pro and Pro Max models show stable or shorter delays compared to last year, while the base model experiences extended waits across regions. This divergence, coupled with a reduced product lineup and the absence of a new 'Air' variant in some markets, suggests that product mix shifts—potentially driven by consumers "spinning down the price curve" due to higher-priced premium models—are influencing availability rather than strong underlying demand, posing a potential risk to Apple's Average Selling Prices and Gross Margins.

Analysis

Analysis from UBS Evidence Lab indicates that initial iPhone 17 wait times present a mixed and uncertain signal for underlying consumer demand. While wait times for the high-end Pro and Pro Max models in the US and Europe are either in line with or shorter than the previous year—with the US Pro Max at 26 days versus 27 for the iPhone 16—the base model is experiencing significantly longer waits. For instance, the iPhone 17 Base model has a 13-day wait in the US, up from 8 days for its predecessor. This divergence suggests a potential shift in product mix rather than a surge in aggregate demand. UBS posits that consumers may be "spinning down the price curve" towards the base model, which now offers double the storage (256GB vs. 128GB) for the same $799 price point. This trend, if it persists, could create a headwind for Apple's Average Selling Prices (ASPs) and Gross Margins. The situation is further complicated by a streamlined launch lineup (seven models versus nine last year) and regional anomalies, such as in China where the new Air model is not yet approved and Pro models are seeing wait times 7-10 days longer than a year ago. Consequently, traditional launch metrics like wait times are proving to be distorted signals, making year-over-year comparisons for underlying demand less reliable.

Key Decisions for Investors

• Investors should closely monitor channel checks and early sales data for confirmation of a negative product mix shift towards the lower-priced base model, as this poses a direct risk to Apple's Average Selling Price and gross margin forecasts.
• It is prudent to discount the reliability of initial wait times as a primary indicator of overall demand and instead focus on management's commentary regarding product mix and regional performance in the upcoming earnings call.
• Consider the divergent demand signals between geographies, particularly the longer high-end wait times in China versus more muted trends in the US, as this regional performance will be critical for modeling revenue and assessing market-specific challenges.